At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AIMD AINOS Inc.
Not Yet Opened 05-11 16:00:00 EDT
1.74
+0.04
+2.35%
盘后1.74
+0.000.00%
19:58 EDT
High1.76Low1.67Vol16.72K
Open1.69D1 Closing1.70Amplitude5.00%
Mkt Cap12.64MTradable Cap5.91MTotal Shares7.27M
T/O28.70KT/O Rate0.49%Tradable Shares3.40M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Ainos updates standard industrial classification code to reflect Smell AI
TIPRANKS  ·  00:01
Ainos updates standard industrial classification code to reflect Smell AI
Ainos director Chiang Yao-Chung reports acquisition of common shares worth $219.3
Reuters  ·  05-08
Ainos director Chiang Yao-Chung reports acquisition of common shares worth $219.3
Ainos director Yao-Chung Chiang reports $511 common share purchase via spouse
Reuters  ·  05-02
Ainos director Yao-Chung Chiang reports $511 common share purchase via spouse
Ainos highlights ‘continued expansion’ of Smell AI deployments
TIPRANKS  ·  04-17
Ainos highlights ‘continued expansion’ of Smell AI deployments
Ainos expands Smell AI deployments into hospital infrastructure with MacKay Memorial Hospital
Reuters  ·  04-17
Ainos expands Smell AI deployments into hospital infrastructure with MacKay Memorial Hospital
ASE Technology Holding Cuts Share Stake in Ainos Inc to 8.4% as of April 12, 2025 From a Stake of 17.0% as of Oct 3, 2025 - SEC Filing
THOMSON REUTERS  ·  04-15
ASE Technology Holding Cuts Share Stake in Ainos Inc to 8.4% as of April 12, 2025 From a Stake of 17.0% as of Oct 3, 2025 - SEC Filing
Ainos partners with MacKay Memorial, Topco to deploy AI Nose in hospitals
Reuters  ·  04-08
Ainos partners with MacKay Memorial, Topco to deploy AI Nose in hospitals
VASRO report flags Ainos Smell AI shift to deployment phase, Q2 rollout momentum
Reuters  ·  04-01
VASRO report flags Ainos Smell AI shift to deployment phase, Q2 rollout momentum
Ainos Q4 EPS $(0.85) Up From $(1.30) YoY, Sales $11.120K
Benzinga  ·  03-31
Ainos Q4 EPS $(0.85) Up From $(1.30) YoY, Sales $11.120K
Ainos FY25 net loss narrows 0.6% to $14.8 million
Reuters  ·  03-30
Ainos FY25 net loss narrows 0.6% to $14.8 million
Correction to AI nose article on March 17 -- WSJ
Dow Jones  ·  03-22
Correction to AI nose article on March 17 -- WSJ
Ainos says WSJ highlights emerging ‘Smell AI’ in article
TIPRANKS  ·  03-19
Ainos says WSJ highlights emerging ‘Smell AI’ in article
Ainos signs deployment of 1,400 AI Nose systems in backend semiconductor environments
Reuters  ·  03-19
Ainos signs deployment of 1,400 AI Nose systems in backend semiconductor environments
The E-Nose Knows: AI Learns to Smell -- Journal Report
Dow Jones  ·  03-18
The E-Nose Knows: AI Learns to Smell -- Journal Report
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26
Reuters  ·  03-12
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26
Ainos to deploy about 200 AI Nose systems in front-end wafer fabs in Q1 2026
Reuters  ·  03-09
Ainos to deploy about 200 AI Nose systems in front-end wafer fabs in Q1 2026
Ainos CEO says AI Nose platform transitioning into industrial deployment
TIPRANKS  ·  03-02
Ainos CEO says AI Nose platform transitioning into industrial deployment
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal
Reuters  ·  03-02
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal
Ainos confirms order for 1,400 AI Nose units under three-year subscription deal
Reuters  ·  02-23
Ainos confirms order for 1,400 AI Nose units under three-year subscription deal
Ainos Reports Promising Interim Results for VELDONA in Feline Gingivostomatitis Trial
Reuters  ·  02-17
Ainos Reports Promising Interim Results for VELDONA in Feline Gingivostomatitis Trial

Introduction

Company Name.
AINOS Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.
Issue price:
--